Elstar Therapeutics
Cambridge
About Elstar Therapeutics
Elstar Therapeutics is fulfilling the promise of precision cancer immunotherapy through a powerful new approach to generating antibody-based, multi-functional therapeutics.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $39.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Jan 2018)
- Website: elstartherapeutics.com
- Phone: (617) 917-4980
Industries & Categories
Biotechnology, Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/elstar-therapeutics-34531 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.